Zobrazeno 1 - 10
of 481
pro vyhledávání: '"M. Alley"'
Publikováno v:
Implementation Science, Vol 18, Iss 1, Pp 1-13 (2023)
Abstract Background Most implementations fail before the corresponding services are ever delivered. Measuring implementation process fidelity may reveal when and why these attempts fail. This knowledge is necessary to support the achievement of posit
Externí odkaz:
https://doaj.org/article/8e686aafee044959848c59ec77662168
Autor:
Henna Budhwani, Zoe M. Alley, Jason E. Chapman, Gregory A. Aarons, Meardith Pooler-Burgess, Karin Coyle, April Idalski Carcone, Karen MacDonnell, Sylvie Naar
Publikováno v:
Implementation Research and Practice, Vol 4 (2023)
Background Adherence to intervention training implementation strategies is at the foundation of fidelity; however, few studies have linked training adherence to trainee attitudes and leadership behaviors to identify what practically matters for the a
Externí odkaz:
https://doaj.org/article/93299157f4824c22b205c3c9106f6baa
Autor:
William M. Alley, Rosemarie Alley
An engaging call to understand and protect groundwater, the primary source of drinking water for almost half of the world's population Groundwater is essential for drinking water and food security. It provides enormous environmental benefits by keepi
Publikováno v:
Implementation Research and Practice, Vol 3 (2022)
Background Clinical supervision is a common quality assurance method for supporting the implementation and sustainment of evidence-based interventions (EBIs) in community mental health settings. However, assessing and supporting supervisor fidelity r
Externí odkaz:
https://doaj.org/article/e1825d60432041fd824aa765aa60fc4b
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Resistance to second-generation androgen receptor (AR) antagonists and CYP17 inhibitors in patients with castration-resistant prostate cancer (CRPC) develops rapidly through reactivation of the androgen signaling axis and has been attributed to AR ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::997103967b585ac8b172658ecb3b7484
https://doi.org/10.1158/1541-7786.c.6541489
https://doi.org/10.1158/1541-7786.c.6541489
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Contains legends to supplementary figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46f3a7d6a33693b28b5123409ea4c0b
https://doi.org/10.1158/1541-7786.22516804.v1
https://doi.org/10.1158/1541-7786.22516804.v1
Autor:
Donald P. McDonnell, Jay C. Strum, Scott A. Lawrence, Rigel J. Kishton, Kimberly J. Cocce, Peter S. Winter, Rachid Safi, Hannah S. White, Victoria O. Haney, Holly M. Alley, Alexander P. Yllanes, John D. Norris, Suzanne E. Wardell, James P. Stice
Supplemental Figure 1. The effects of G1T28 are due to CDK4/6 inhibition. Supplemental Figure 2. Analysis of pharmacodynamics endpoints indicates on-target activity in 22Rv1 tumors. A. Supplemental Figure 3. G1T38 and G128 have similar in vitro effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d35094806626b4a693938067925dfd
https://doi.org/10.1158/1541-7786.22516801.v1
https://doi.org/10.1158/1541-7786.22516801.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shunqiang Li, Donald P. McDonnell, John D. Norris, Jin-Ping Lai, Robert Crowder, Jieya Shao, Elizabeth Griffin, Tina Primeau, Kim T. Arndt, Stephen G. Dann, Todd VanArsdale, Koleen Eisele, Holly M. Alley, Matthew J. Ellis, Suzanne E. Wardell
Supplemental figure 4: Evaluation of pharmacodynamics endpoints confirms on target activity of SERDs and palbociclib, resulting in sustained inhibition of tumors receiving both treatments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee29c5e6c07b5a865bf126f1bef796e
https://doi.org/10.1158/1078-0432.22454688
https://doi.org/10.1158/1078-0432.22454688
Autor:
Shunqiang Li, Donald P. McDonnell, John D. Norris, Jin-Ping Lai, Robert Crowder, Jieya Shao, Elizabeth Griffin, Tina Primeau, Kim T. Arndt, Stephen G. Dann, Todd VanArsdale, Koleen Eisele, Holly M. Alley, Matthew J. Ellis, Suzanne E. Wardell
Supplemental figure 1: SERDs and SERMs differ in their ability to inhibit ER-dependent stimulation of breast cancer cell proliferation by growth factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45421649f6c61cc430618d3b84ec6afd
https://doi.org/10.1158/1078-0432.22454700
https://doi.org/10.1158/1078-0432.22454700